I'd gamble on this if it were below 4 cents. I don't see tax loss selling as being done in early OCT. I could be wrong but the momo here is anything but bullish. The stock, without any revenue and fighting legislation just doesn't rate a buy. Risk is too high, JMO.
Hey raj had to check geron again read bold paragraph 3 paragraph's done it states
Currently there are no sites enrolling patients for this study. The Investigational New Drug application (IND) has been placed on clinical hold by the FDA pending data from a nonclinical animal study being conducted by the company.
Just like to add geron never had sites even when they had approval